Hence, the concurrent expression of CD4+ and CD8+ co-receptor most likely provided additional survival signal for tumor-specific CD4+ T cells, which did not, however, translate into classical helper functions towards CD8+ T cells (40, 44, 45). The gene discussed is CD8A; the disease is neoplasm.